Abstract
["Purpose: We conducted a network meta-analysis to evaluate the efficacy and toxicity of cetuximab and nimotuzumab in the treatment of advanced nasopharyngeal carcinoma (NPC).","Methods: A systematic literature search was performed though Pubmed, Embase, Cochran Library, China National Knowledge Infrastructure (CNKI), Chinese Biomedical (CBM) and Wanfang databases. Totally, 19 randomized controlled trials (RCTs) (n=1201) met the study selection criteria and were incorporated in this network meta analysis.","Results: Compared with cetuximab, the results of network meta-analysis indicated that nimotuzumab may achieve higher complete remission rate (CRR) or overall remission rate (ORR) of the primary tumor, but no difference was noticed in 1- and 2-year overall survival (OS) rate and certain toxicities such as myelosuppression, radiodermatitis, mucositis and gastrointestinal reactions. Although nimotuzumab increased the 3-year OS rate, compared with cetuximab, this result needs to be interpreted cautiously because of the studies' heterogeneity.","Conclusion: Even though we didn't find significant difference between cetuximab and nimotuzumab in terms of survival outcomes, nimotuzumab is more advantageous in short-term efficacy."]
| Original language | English |
|---|---|
| Pages (from-to) | 1004-1010 |
| Number of pages | 7 |
| Journal | Journal of B.U.ON. |
| Volume | 22 |
| Issue number | 4 |
| State | Published - Jul 2017 |
Funding
This study was funded by the Natural Science Foundation of Hubei Province, China (grant no. 2014CFB312), the Key Supporting Project of Scientific Research of Health and Family Planning Commission of Hubei Province, China (grant no.WJ20172026) and the Science Foundation of Hubei Key Laboratory of Tumor Microenvironment and Immunothrapy (grant no. 2015 KZL10).
Keywords
- cetuximab
- nasopharyngeal carcinoma
- network meta-analysis
- nimotuzumab
Indexed by
- SCIE
- Scopus
Fingerprint
Dive into the research topics of 'Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver